I am a...
General Information Patients & Carers Health Care Professional in the US Health Care Professional outside the US Journalists Jobseekers

We passionately improve health

Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.

Research Approach

Research & Development

Research Approach

Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need.

Read moreon

Research Approach

Careers

Working at Boehringer Ingelheim – Being part of a global family

As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.

Read moreon

Working at Boehringer Ingelheim – Being part of a global family
Animal Health: One business, one vision, one global leader in disease prevention and treatment

-

Animal Health: One business, one vision, one global leader in disease prevention and treatment

By bringing together the best minds in the business, Boehringer Ingelheim and Merial have united to create one animal health company with the portfolio, scale and talent to make the industry even better at improving animal health.

Read moreon

Animal Health: One business, one vision, one global leader in disease prevention and treatment
Cancer Immunology at Boehringer Ingelheim

Therapeutic Areas

Cancer Immunology at Boehringer Ingelheim

Scientists at Boehringer Ingelheim are exploring exciting new approaches to turn up the heat on cancer by firing up our immune systems in a tumor-specific manner.

Read moreon

Cancer Immunology at Boehringer Ingelheim

DOWNLOAD PDF (249.56 KB)

Partnering Day, London, UK
Thursday 26th April, 2018

Meet our research and partnering leadership teams, learn more about our partnering interests and discover our approach to research and partnering.

View PDFof

Partnering Day, London, UK
Thursday 26th April, 2018

Research & Development

R&D Press Conference, April 25, 13:30 CET

Learn more about our Human Pharma pipeline and see how we transcend disease boundaries at the R&D Press Conference.

Read moreon

R&D Press Conference, April 25, 13:30 CET

Explore Our Content